Mr. Adel Abdullah Alghamdi is a regulatory affairs and quality systems specialist with over 8 years of experience in biopharmaceuticals, biologics, and advanced therapies. He has worked extensively with global and regional regulatory frameworks (SFDA, FDA, EMA, PIC/S) and has contributed to GMP inspections, technology transfer, and biotech localization initiatives in Saudi Arabia under Vision 2030.

Mr. Alghamdi is passionate about mentoring startups and enabling regulatory readiness to accelerate biotech innovation.

His work bridges compliance, facility readiness, and multi-agency collaboration to advance national biotech capabilities. He currently serves as Senior GMP Inspection Expert at the Saudi Food and Drug Authority (SFDA), where he leads inspections for local and international biopharma facilities.

Mr. Alghamdi's experience spans upstream and downstream production, validation audits, and regulatory alignment with SFDA, FDA, EMA, and PIC/S standards. He holds an MSc in Bioprocess Engineering from Dublin City University and has trained internationally in GMP Annex 1 & 16, downstream processing, and biopharma solutions. He is a certified PMP and has contributed to global forums in Ireland, the UK, and the US.

As a mentor and lecturer, Mr. Adel Alghamdi brings deep insight into regulatory strategy, facility design, and biotech policy - empowering founders to navigate compliance and scale with confidence.